{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T23:15:12Z","timestamp":1768000512717,"version":"3.49.0"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5783,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver Transpl"],"published-print":{"date-parts":[[1999,11]]},"DOI":"10.1002\/lt.500050605","type":"journal-article","created":{"date-parts":[[2004,7,28]],"date-time":"2004-07-28T07:20:58Z","timestamp":1090999258000},"page":"491-496","source":"Crossref","is-referenced-by-count":128,"title":["Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation"],"prefix":"10.1002","volume":"5","author":[{"given":"Francis Y.","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Osorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred F.","family":"Poordad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie N.","family":"Briceno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Garcia-Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert R.","family":"Gish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,12,30]]},"reference":[{"key":"10.1002\/lt.500050605-BIB1|cit1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/hep.1840130402","article-title":"Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease","volume":"13","author":"Todo","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB2|cit2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0168-8278(92)90138-F","article-title":"Hepatitis B virus reinfection after orthotopic liver transplantation: Serologic and clinical implications","volume":"14","author":"O'Grady","year":"1992","journal-title":"J Hepatol"},{"key":"10.1002\/lt.500050605-BIB3|cit3","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hep.1840130429","article-title":"Liver transplantation for patients with hepatitis B: What have we learned from our results?","volume":"13","author":"Lake","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB4|cit4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840130122","article-title":"Hepatic histologic findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis","volume":"13","author":"Davies","year":"1991","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1002\/lt.500050605-BIB6|cit6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(91)92515-4","article-title":"Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients","volume":"337","author":"Samuel","year":"1991","journal-title":"Lancet"},{"key":"10.1002\/lt.500050605-BIB7|cit7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0168-8278(91)90869-D","article-title":"Liver transplantation in HBs antigen (HBsAg) carriers: Prevention of hepatitis B virus (HBV) recurrence by passive immunization","volume":"13","author":"M\u00fcller","year":"1991","journal-title":"J Hepatol"},{"key":"10.1002\/lt.500050605-BIB8|cit8","first-page":"3622","article-title":"Outcome following orthotopic liver transplantation in HBsAg-positive patients using short- or long-term immunoprophylaxis","volume":"26","author":"Lemmens","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050605-BIB9|cit9","first-page":"418","article-title":"Liver transplantation in hepatitis B surface antigen-positive patients with postoperative long-term immunoprophylaxis","volume":"2","author":"Langrehr","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1002\/lt.500050605-BIB10|cit10","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/lt.500020603","article-title":"Liver transplantation in HBsAg-positive HBV DNA-negative cirrhotics: Immunoprophylaxis and long-term outcome","volume":"2","author":"Grazi","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"10.1002\/lt.500050605-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1002\/hep.510240601","article-title":"Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin","volume":"24","author":"Terrault","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/00007890-199605150-00013","article-title":"Improved outcome of orthotopic liver transplantation for chronic hepatitis cirrhosis with aggressive passive immunization","volume":"61","author":"McGory","year":"1996","journal-title":"Transplantation"},{"key":"10.1002\/lt.500050605-BIB13|cit13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/lt.500010414","article-title":"Should liver transplantation be performed for patients with chronic hepatitis B?","volume":"1","author":"Lake","year":"1995","journal-title":"Liver Transpl Surg"},{"key":"10.1002\/lt.500050605-BIB14|cit14","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7326\/0003-4819-126-10-199705150-00012","article-title":"Liver transplantation and hepatitis B","volume":"125","author":"Poterucha","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1002\/lt.500050605-BIB15|cit15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/hep.510270133","article-title":"Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis","volume":"27","author":"Ghany","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB16|cit16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.510270138","article-title":"Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation","volume":"27","author":"Protzer-Knolle","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB17|cit17","first-page":"313A","article-title":"Long-term results of liver transplantation in HBsAg-positive patients receiving anti-HBsAg passive immunoprophylaxis [abstract]","volume":"28","author":"Samuel","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB18|cit18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM199807093390201","article-title":"A one-year trial of lamivudine for chronic hepatitis B","volume":"339","author":"Lai","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1002\/lt.500050605-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1235A","DOI":"10.1016\/S0016-5085(98)85010-5","article-title":"Lamivudine treatment for one year in previously untreated US hepatitis B patients: Histologic improvement and hepatitis B e antigen (HBeAg) seroconversion [abstract]","volume":"114","author":"Dienstag","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1002\/lt.500050605-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0140-6736(96)04444-3","article-title":"Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis","volume":"348","author":"Grellier","year":"1996","journal-title":"Lancet"},{"key":"10.1002\/lt.500050605-BIB21|cit21","first-page":"182A","article-title":"Lamivudine for hepatitis B after liver transplantation (OLT) [abstract]","volume":"24","author":"Perrilo","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB22|cit22","first-page":"182A","article-title":"Efficacy of lamivudine for prophylaxis and treatment of hepatitis B in liver transplant patients [abstract]","volume":"24","author":"Markowitz","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB23|cit23","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/hep.510270628","article-title":"Identification and characterization of mutation in hepatitis B virus resistant to lamivudine","volume":"27","author":"Allen","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB24|cit24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/hep.510240339","article-title":"Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine","volume":"3","author":"Ling","year":"1996","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/S0168-8278(97)80125-0","article-title":"Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation","volume":"26","author":"Aye","year":"1997","journal-title":"J Hepatol"},{"key":"10.1002\/lt.500050605-BIB26|cit26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(96)02266-0","article-title":"Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation","volume":"9044","author":"Bartholomew","year":"1997","journal-title":"Lancet"},{"key":"10.1002\/lt.500050605-BIB27|cit27","first-page":"262A","article-title":"Lack of efficacy of lamivudine for HBV infection after liver transplantation [abstract]","volume":"28","author":"Dodson","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB28|cit28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00002030-199509040-00006","article-title":"Development of HIV-1 resistance to 2\u20323\u2032-dideoxy-3\u2032-thiacytidine in patients with AIDS or advanced AIDS-related complex","volume":"9","author":"Wainberg","year":"1995","journal-title":"AIDS"},{"key":"10.1002\/lt.500050605-BIB29|cit29","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1073\/pnas.90.12.5653","article-title":"Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3\u2032thicytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase","volume":"90","author":"Tisdale","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1002\/lt.500050605-BIB30|cit30","first-page":"49A","article-title":"Quantitative anti-HBs titers during intramuscular (IM) hepatitis B immunoglobulin (HBIG) administration post-liver transplantation (LT) for hepatitis B [abstract]","volume":"16","author":"Villamil","year":"1992","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB31|cit31","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.510280241","article-title":"Prophylaxis against hepatitis B recurrence following liver transplantation using lamivudine and hepatitis B immune globulin","volume":"28","author":"Markowitz","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB32|cit32","first-page":"389A","article-title":"Combined short-term hepatitis B immunoglobulin (HBIG) and long-term lamivudine (LAM) versus HBIG monotherapy as hepatitis B virus (HBV) prophylaxis in liver transplant recipients [abstract]","volume":"28","author":"Terrault","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB33|cit33","first-page":"262A","article-title":"Substitution of lamivudine for long-term HBIG after liver transplantation for hepatitis B-related liver disease [abstract]","volume":"28","author":"Dodson","year":"1998","journal-title":"Hepatology"},{"key":"10.1002\/lt.500050605-BIB34|cit34","first-page":"263A","article-title":"Prophylactic lamivudine and very low-dose HBIG prevent HBV recurrence post-liver transplant whilst rescue therapy with lamivudine is associated with significant resistance and graft loss [abstract]","volume":"28","author":"McCaughan","year":"1998","journal-title":"Hepatology"}],"container-title":["Liver Transplantation and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.500050605","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/lt.500050605","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T01:55:33Z","timestamp":1734486933000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/lt.500050605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1999,11]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.500050605","relation":{},"ISSN":["1074-3022"],"issn-type":[{"value":"1074-3022","type":"print"}],"subject":[],"published":{"date-parts":[[1999,11]]}}}